Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
28 March 2025 | Story Tshepo Tsotetsi | Photo Supplied
faculty of the Humanities graduation
Congratulations to our UFS leaders of the future!

As the leaves turn and autumn settles over the Free State, a new season of celebration is upon us. Gowns are being dusted off, caps are ready to be tossed, and excitement is building as the University of the Free State (UFS) prepares to honour the Class of 2024. From 4 to 5 April 2025, the Qwaqwa Campus will host its graduation ceremonies, followed by the Bloemfontein Campus from 8 to 12 April 2025.

This year, a total of 7 994 students will walk the stage, marking a significant moment in their academic journeys. The university will host 20 graduation ceremonies across its Qwaqwa and Bloemfontein Campuses, celebrating the accomplishments of graduates across all faculties. In addition to awarding degrees and diplomas, the UFS will also confer three honorary doctorates, recognising exceptional contributions in various fields.

Graduation is more than just a ceremony; it is a defining moment. It marks the end of years of late-night studying, countless assignments, and moments of self-doubt. But more importantly, it signals the beginning of something new. Armed with their degrees, the UFS graduates will soon step into the world beyond university, ready to make their mark.

At the UFS, excellence is more than a value – it is a standard. Every graduate walking across the stage embodies the university’s commitment to producing individuals who are not only knowledgeable but also adaptable, resilient, and prepared for the ever-changing demands of the world. This is at the heart of Vision 130, UFS’s roadmap to 2034, which focuses on shaping graduates who will contribute meaningfully to both local and global communities.

For the Class of 2024, the journey has been long, challenging, and rewarding. Now, as they prepare to walk the stage, one thing is certain: the future is theirs to shape.

 

Click to view document WATCH: 2025 Graduation Livestream 

 

Click to view documentClick here to see the full schedule for the 2025 April graduations.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept